Tilray has seen widespread insider buying - C level's buying lots of Shares.
In January TILRAY saw major buys from the CEO, COO and General Council all acquired more shares of their employer. As Joe Biden makes campaign promises about legalizing cannabis, the fact remains that most institutional money has very small positions in the industry. Regardless of his promises - Tilray is incredibly oversold. The current price presents a terrific opportunity for longterm investors.
INSIDER NAME |
|
TRANSACTION |
DATETRANSACTION DATE |
NUM OF SHARESDIVIDEND AMOUNT |
PRICE |
TOTALTRANSACTION TOTAL |
REMAINSHARES AFTER |
Denise Menikheim
Faltischek |
|
Buy |
01/17/24 |
10,000 |
2.05000 |
20,500 |
293,269 |
Mitchell Gendel |
|
Buy |
01/16/24 |
7,200 |
1.98000 |
14,256 |
195,796 |
Mitchell Gendel |
|
Buy |
01/12/24 |
5,400 |
1.87000 |
10,097 |
188,596 |
Irwin David Simon |
|
Buy |
01/12/24 |
53,700 |
1.88000 |
100,956 |
2,033,058 |
Carl Merton |
|
Buy |
01/12/24 |
20,000 |
1.87000 |
37,400 |
450,325 |
Comments
Post a Comment